Beijing Tiantan Biological Products Corp Ltd Cash Flow-to-Debt Ratio
Beijing Tiantan Biological Products Corp Ltd cash flow-to-debt ratio. Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow-to-Debt Ratio of 0.20x as of September 2025, meaning its operating cash flow of CN¥318.80 Million could theoretically repay 0% of its total liabilities (CN¥1.60 Billion) in one year. Check Beijing Tiantan Biological Products Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Cash flow-to-debt ratio of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. Historical debt coverage capacity for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Check Beijing Tiantan Biological Products Corp earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Beijing Tiantan Biological Products Corp Ltd Cash Flow-to-Debt Ratio by Year (1998–2024)
Beijing Tiantan Biological Products Corp Ltd cash flow-to-debt ratio by year from 1998 to 2024. Year-by-year debt coverage analysis for Beijing Tiantan Biological Products Corp Ltd. For the full cash flow conversion analysis, see 600161 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.61x | CN¥819.78 Million | CN¥1.34 Billion | ▼ -63.3% |
| 2023 | 1.67x | CN¥2.39 Billion | CN¥1.43 Billion | ▲ +134.9% |
| 2022 | 0.71x | CN¥1.13 Billion | CN¥1.58 Billion | ▼ -5.0% |
| 2021 | 0.75x | CN¥980.35 Million | CN¥1.31 Billion | ▲ +60.9% |
| 2020 | 0.46x | CN¥702.11 Million | CN¥1.51 Billion | ▼ -17.7% |
| 2019 | 0.57x | CN¥642.47 Million | CN¥1.14 Billion | ▼ -40.0% |
| 2018 | 0.94x | CN¥677.92 Million | CN¥720.19 Million | ▲ +107.5% |
| 2017 | 0.45x | CN¥218.39 Million | CN¥481.46 Million | ▲ +253.9% |
| 2016 | 0.13x | CN¥428.37 Million | CN¥3.34 Billion | ▼ -8.0% |
| 2015 | 0.14x | CN¥473.26 Million | CN¥3.40 Billion | ▲ +10.7% |
| 2014 | 0.13x | CN¥477.95 Million | CN¥3.80 Billion | ▼ -23.2% |
| 2013 | 0.16x | CN¥566.43 Million | CN¥3.46 Billion | ▲ +14.8% |
| 2012 | 0.14x | CN¥432.00 Million | CN¥3.03 Billion | ▼ -28.2% |
| 2011 | 0.20x | CN¥353.15 Million | CN¥1.78 Billion | ▲ +40.3% |
| 2010 | 0.14x | CN¥184.85 Million | CN¥1.31 Billion | ▼ -61.7% |
| 2009 | 0.37x | CN¥448.23 Million | CN¥1.21 Billion | ▼ -41.2% |
| 2008 | 0.63x | CN¥276.39 Million | CN¥439.35 Million | ▲ +51.3% |
| 2007 | 0.42x | CN¥153.55 Million | CN¥369.34 Million | ▼ -4.1% |
| 2006 | 0.43x | CN¥154.36 Million | CN¥356.20 Million | ▼ -40.9% |
| 2005 | 0.73x | CN¥131.69 Million | CN¥179.67 Million | ▼ -16.3% |
| 2004 | 0.88x | CN¥110.11 Million | CN¥125.70 Million | ▲ +121.7% |
| 2003 | 0.40x | CN¥62.93 Million | CN¥159.24 Million | ▲ +1.0% |
| 2002 | 0.39x | CN¥84.38 Million | CN¥215.73 Million | ▲ +46.1% |
| 2001 | 0.27x | CN¥46.49 Million | CN¥173.64 Million | ▼ -6.8% |
| 2000 | 0.29x | CN¥47.90 Million | CN¥166.77 Million | ▲ +7.8% |
| 1999 | 0.27x | CN¥42.58 Million | CN¥159.88 Million | ▲ +26.4% |
| 1998 | 0.21x | CN¥23.71 Million | CN¥112.54 Million | — |